Pat Cummins, the Australian cricket captain, is backing a $65 million raise by Melbourne-based healthcare start-up Everlab.
What happened?
Everlab will use the funds to take its technology global, starting with the United Kingdom, as demand for its diagnostic screening technology takes off.
The company's co-founder and chief executive, Marc Hermann, said the funding will last for the next four to five years, allowing for more aggressive growth.
Why it matters for Pat Cummins
Pat Cummins' investment in Everlab marks a significant move into the healthcare sector, with the company's technology focusing on early disease detection.
The funding round, announced on 16 Jun, will enable Everlab to expand its operations and reach new markets.
What comes next?
With the $65 million raise, Everlab plans to establish a presence in the UK, with further expansion planned in the coming years.
The company's technology uses advanced diagnostics and tests to detect potential diseases in patients early, with the goal of improving health outcomes.
On 16 Jun, Everlab's co-founder and chief executive, Marc Hermann, confirmed the funding would support the company's growth plans.
The investment by Pat Cummins, announced on the same day, is a significant vote of confidence in Everlab's technology and growth potential.
As the company moves forward with its expansion plans, Pat Cummins' involvement is likely to draw attention to the importance of early disease detection.
The Australian cricket captain's investment in Everlab is a notable example of an athlete investing in a healthcare start-up, with the potential for significant returns.
With the UK expansion planned, Everlab's technology is set to reach a wider audience, with the potential to improve health outcomes for thousands of people.
The $65 million funding round, backed by Pat Cummins, will play a key role in driving Everlab's growth and expansion plans.